Buprenorphine Hydrochloride And Naloxone Hydrochloride Dihydrate 67296-2191-01
- Manufacturer
- Redpharm Drug
- Dosage Form
- Tablet
- Route
- Sublingual
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CIII
- Marketing Start
- September 1, 2020
- Listing Expires
- December 31, 2027
- Application
- ANDA209069
Active Ingredients
| Ingredient | Strength |
|---|---|
| Buprenorphine Hydrochloride | 8 mg/1 |
| Naloxone Hydrochloride Dihydrate | 2 mg/1 |
Drug Class
Opioid Antagonist [EPC]Opioid Antagonists [MoA]Partial Opioid Agonist [EPC]
Selected Package
67296-2191-01Selected12 TABLET in 1 BOTTLE, PLASTIC (67296-2191-1)
Other packages for this product(1)
6 TABLET in 1 BOTTLE, PLASTIC (67296-2191-6)
External Resources